Perioperative use of anti-platelet drugs
Détails
ID Serval
serval:BIB_20C9E2DCF538
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Perioperative use of anti-platelet drugs
Périodique
Best Practice and Research. Clinical Anaesthesiology
ISSN
1753-3740 (Print)
Statut éditorial
Publié
Date de publication
06/2007
Volume
21
Numéro
2
Pages
241-56
Notes
Journal Article
Review --- Old month value: Jun
Review --- Old month value: Jun
Résumé
Performing a surgical procedure on a patient undergoing anti-platelet therapy raises a dilemma: is it safer to withdraw the drugs and reduce the haemorrhagic risk, or to maintain them and reduce the risk of myocardial ischaemic events? Based on recent clinical data, this review concludes that the risk of coronary thrombosis on anti-platelet drugs withdrawal is much higher than the risk of surgical bleeding when maintaining them. In secondary prevention, aspirin is a lifelong therapy and should never be stopped. Clopidogrel is mandatory as long as the coronary stents are not fully endothelialized, which takes 6-24 weeks depending on the technique used, but might be required for a longer period.
Mots-clé
Aspirin/therapeutic use
Coronary Thrombosis/*prevention & control
Hemorrhage/*chemically induced
Humans
Perioperative Care
Platelet Aggregation Inhibitors/adverse effects/*therapeutic use
Stents
Surgical Procedures, Elective
Ticlopidine/analogs & derivatives/therapeutic use
Time Factors
Treatment Outcome
Pubmed
Création de la notice
28/01/2008 10:48
Dernière modification de la notice
20/08/2019 13:57